Limitations of ctDNA as a Biomarker
“Low quantity, fragment heterogeneity, false results and analytical difficulties are some common limitations of using ctDNA as a biomarker.” Circulating tumor DNA is free fragments of DNA released by tumor …
“Low quantity, fragment heterogeneity, false results and analytical difficulties are some common limitations of using ctDNA as a biomarker.” Circulating tumor DNA is free fragments of DNA released by tumor …
“Circulating tumor DNA is present in the bloodstream and secreted by cancer cells. Recent studies suggest that scientists use these DNA fragments to study cancer. But is ctDNA a biomarker? …
“Microsatellite instability is defined as indel (insertion or deletion) mutations within the repetitive regions (microsatellite) in cancer cells by the inactivation of DNA mismatch repair proteins.“ Do you know? Introns …
Role of Microsatellite Instability (MSI) in cancer (MSI-H, MSI-I and MSS) Read More »